<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00720460</url>
  </required_header>
  <id_info>
    <org_study_id>080185</org_study_id>
    <secondary_id>08-H-0185</secondary_id>
    <nct_id>NCT00720460</nct_id>
  </id_info>
  <brief_title>Technical Development of Interventional Cardiovascular Magnetic Resonance Imaging in Normal Volunteers</brief_title>
  <official_title>Technical Development of Interventional Cardiovascular Magnetic Resonance Imaging in Healthy Volunteers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Institutes of Health Clinical Center (CC)</source>
  <brief_summary>
    <textblock>
      This study will test new techniques to image the heart, blood vessels, and legs using&#xD;
      magnetic resonance imaging (MRI). The techniques will be used to plan and guide treatments&#xD;
      using minimally invasive methods.&#xD;
&#xD;
      Healthy normal volunteers 18 years of age and older may be eligible for this study.&#xD;
&#xD;
      For MRI, the subject lies flat on a table that can slide in and out of the scanner, a metal&#xD;
      cyclinder. Special antennas, covered in pads, are placed against the subject s body. The scan&#xD;
      time can vary from 20 minutes to 2 hours, with most scans lasting between 45 and 90 minutes.&#xD;
      The subject may be asked to wear adhesive patches on the chest for monitoring the heart and a&#xD;
      belt or finger pad for monitoring breathing. During the test, a contrast agent called&#xD;
      gadolinium may be injected. This substance brightens the heart and arteries during the scan,&#xD;
      providing a better picture of blood flow.&#xD;
&#xD;
      During the procedure, subjects may be asked to exercise their legs on a machine to evaluate&#xD;
      the effects of motion and exercise on the MRI exam.&#xD;
&#xD;
      Large blood pressures cuffs may be placed on either or both thighs or calves to try to&#xD;
      measure arterial flow to the legs. The cuffs are inflated to a pressure as high as at least&#xD;
      50 mmHg higher than thesubject s systolic blood pressure (up to 250 mmHg) for up to 10&#xD;
      minutes.&#xD;
&#xD;
      Subjects may be asked to return for repeated scans.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We will evaluate new developments in fast magnetic resonance imaging (MRI) of the heart and&#xD;
      blood vessels on healthy volunteers. These studies will be conducted in the NIH MRI systems&#xD;
      located at the NIH Clinical Center in Bethesda, Maryland. These procedures may involve the&#xD;
      intravenous administration of commercially available MR contrast media, supine exercise or&#xD;
      the inflation of blood pressure cuffs on the lower extremities during the MRI imaging. The&#xD;
      results will be used to evaluate the performance of various research pulse sequences,&#xD;
      gradient coils, and radiofrequency receiver coils on human subjects and will provide&#xD;
      essential ground work for specific patient protocols, both diagnostic and therapeutic.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <start_date>July 18, 2008</start_date>
  <completion_date>November 2, 2018</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>To develop and test new and incremental approaches to fast cardiovascular MRI in healthy human subjects. (healthy volunteers)</measure>
    <time_frame>Day of study</time_frame>
    <description>There are 24 objectives listed in the protocol as potential outcomes.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">107</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Experimental</arm_group_label>
    <description>Healthy Volunteers</description>
  </arm_group>
  <eligibility>
    <criteria>
      <textblock>
        -  1. GENERAL INCLUSION CRITERIA:&#xD;
&#xD;
          -  Healthy adult volunteers, age is greater than 18 years of age, who consent to&#xD;
             participate in writing&#xD;
&#xD;
             2. EXCLUSION CRITERIA: MRI risk&#xD;
&#xD;
          -  Cardiac pacemaker or implantable defibrillator&#xD;
&#xD;
          -  Cerebral aneurysm clip&#xD;
&#xD;
          -  Implanted neural stimulator (e.g. TENS-Unit)&#xD;
&#xD;
          -  Any type of ear or cochlear implant&#xD;
&#xD;
          -  Intra-ocular foreign body (e.g. metal shavings)&#xD;
&#xD;
          -  Any implanted device (e.g. insulin pump, drug infusion device)&#xD;
&#xD;
          -  Metal shrapnel or bullet&#xD;
&#xD;
          -  Morbid obesity&#xD;
&#xD;
          -  Claustrophobia&#xD;
&#xD;
             3. EXCLUSION CRITERIA: Contrast media risk:&#xD;
&#xD;
          -  Pregnant women (when uncertain, subjects will undergo urine or blood testing) or&#xD;
             lactating women&#xD;
&#xD;
          -  Known hemoglobinopathy&#xD;
&#xD;
          -  Known kidney disease&#xD;
&#xD;
          -  Exposure to gadolinium MRI contrast agents in the past 18 hours, if the study requires&#xD;
             gadolinium MRI contrast agent.&#xD;
&#xD;
          -  Diabetes&#xD;
&#xD;
          -  Children are not included.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Robert J Lederman, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Heart, Lung, and Blood Institute (NHLBI)</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National Institutes of Health Clinical Center, 9000 Rockville Pike</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <zip>20892</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Lederman RJ. Cardiovascular interventional magnetic resonance imaging. Circulation. 2005 Nov 8;112(19):3009-17. Review.</citation>
    <PMID>16275886</PMID>
  </reference>
  <reference>
    <citation>Haustein J, Laniado M, Niendorf HP, Louton T, Beck W, Planitzer J, Schöffel M, Reiser M, Kaiser W, Schörner W, et al. Triple-dose versus standard-dose gadopentetate dimeglumine: a randomized study in 199 patients. Radiology. 1993 Mar;186(3):855-60.</citation>
    <PMID>8430199</PMID>
  </reference>
  <reference>
    <citation>Niendorf HP, Haustein J, Cornelius I, Alhassan A, Clauss W. Safety of gadolinium-DTPA: extended clinical experience. Magn Reson Med. 1991 Dec;22(2):222-8; discussion 229-32. Review.</citation>
    <PMID>1812350</PMID>
  </reference>
  <verification_date>November 2, 2018</verification_date>
  <study_first_submitted>July 19, 2008</study_first_submitted>
  <study_first_submitted_qc>July 19, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 22, 2008</study_first_posted>
  <last_update_submitted>December 13, 2019</last_update_submitted>
  <last_update_submitted_qc>December 13, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 16, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Magnetic Resonance Imaging</keyword>
  <keyword>Minimally Invasive Therapy</keyword>
  <keyword>Transcatheter Therapeutics</keyword>
  <keyword>Healthy Volunteers</keyword>
  <keyword>Gadolinium Contrast</keyword>
  <keyword>Healthy Volunteer</keyword>
  <keyword>HV</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

